| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |